Top Markets
Coin of the day
AVAX Technologies, Inc. AVAX Technologies, Inc.

AVAX Technologies, Inc.

AVXT
Rangering i aksjer #41955
AVAX Technologies, Inc. is an emerging biopharmaceutical company focused on... AVAX Technologies, Inc. is an emerging biopharmaceutical company focused on pioneering autologous cell vaccine methods for cancer therapy. Its pipeline includes lead candidates M-VAX, for melanoma, and O-VAX, targeting ovarian cancer, both of which have successfully concluded Phase II clinical trials. The firm is also developing LungVax, a potential treatment for non-small cell lung cancer. Established in 1990, the Philadelphia, Pennsylvania-based entity initially operated as Walden Laboratories, Inc. before adopting its current name, AVAX Technologies, Inc., in March 1996.
Aksjekurs
$0.00001
Sist synkronisert: 2025-12-30
Markedsverdi
$6.89K
Endring (1 dag)
0.00%
Endring (1 år)
0.00%
Land
US
Handel AVAX Technologies, Inc. (AVXT)

Kategori

Utbyttehistorikk for AVAX Technologies, Inc. (AVXT)
AVAX Technologies, Inc. (aksjesymbol: AVXT) har gitt totalt 0 utbyttebetalinger.
Summen av alle utbytter (justert for aksjesplitt): 0.00
Utbytteavkastning (TTM): 0
Utbyttebetalinger for AVAX Technologies, Inc. (AVXT) fra 2026 til 2026
Årlige utbyttebetalinger
År Utbytte (justert for aksjesplitt) Endre
Ikke nok data for de angitte datoene.
Liste over alle utbyttebetalinger
År Utbytte Endre
Ikke nok data for de angitte datoene.
Utbyttebetalinger for lignende selskaper eller konkurrenter
Selskap Antall utbyttebetalinger Land
0.00%
US
0.00%
NL
0.00%
CH
29.00%
BE
0.00%
KR